Hip pathologies in mucopolysaccharidosis type III
Breyer S, Vettorazzi E, Schmitz L, Gulati A, von Cossel K, Spiro A, Rupprecht M, Stuecker R, Muschol N
J ORTHOP SURG RES. 2021;16(1):.

Assessment of Peripheral Nervous System Alterations in Patients with the Fabry Related GLA-Variant p.A143T
Godel T, V Cossel K, Friedrich R, Glatzel M, Canaan-Kühl S, Duning T, Kronlage M, Heiland S, Bendszus M, Muschol N, Mautner V
DIAGNOSTICS. 2020;10(12):.

Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS)
Lenders M, Nordbeck P, Kurschat C, Karabul N, Kaufeld J, Hennermann J, Patten M, Cybulla M, Müntze J, Üçeyler N, Liu D, Das A, Sommer C, Pogoda C, Reiermann S, Duning T, Gaedeke J, Stumpfe K, Blaschke D, Brand S, Mann W, Kampmann C, Muschol N, Canaan-Kühl S, Brand E
CLIN PHARMACOL THER. 2020;108(2):326-337.

Dorsal root ganglia volume is increased in patients with the Fabry-related GLA variant p.D313Y
Godel T, Bäumer P, Stumpfe K, Muschol N, Kronlage M, Brunnée M, Kollmer J, Heiland S, Bendszus M, Mautner V
J NEUROL. 2019;266(6):1332-1339.

Obstructive sleep apnea and craniofacial appearance in MPS type I-Hurler children after hematopoietic stem cell transplantation
Koehne T, Müller-Stöver S, Köhn A, Stumpfe K, Lezius S, Schmid C, Lukacs Z, Kahl-Nieke B, Muschol N
SLEEP BREATH. 2019;23(4):1315-1321.

Letzte Aktualisierung aus dem FIS: 17.04.2024 - 00:39 Uhr